Please login to the form below

Not currently logged in


This page shows the latest Kaletra news and features for those working in and with pharma, biotech and healthcare.

AbbVie’s HIV therapy Kaletra fails to show efficacy in COVID-19

AbbVie’s HIV therapy Kaletra fails to show efficacy in COVID-19

In the RECOVERY trial, 1, 616 patients were randomised to receive Kaletra, compared to 3, 424 patients who received standard-of-care. ... In June, the World Health Organization halted the evaluation of Kaletra treatment in its SOLIDARITY trial of

Latest news

More from news
Approximately 3 fully matching, plus 27 partially matching documents found.

Latest Intelligence

  • As COVID-19 takes over the world, biopharma fights back As COVID-19 takes over the world, biopharma fights back

    19. Kaletra combines two antivirals, lopinavir and ritonavir, and is already approved for use as a treatment for HIV. ... who].were late in infection and already had considerable tissue damage”. However, the study also found that Kaletra is unable to

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company
certain health

Transforming the way health brands and companies communicate, we deliver creative science led, insight-driven solutions that give award winning results...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...